G1 Therapeutics, Inc. (GTHX) Tops Q4 EPS by 8c

G1 Therapeutics, Inc. (NASDAQ: GTHX) reported Q4 EPS of ($0.73), $0.08 better than the analyst estimate of ($0.81). Revenue for the quarter came in at $10.25 million versus the consensus estimate of $9.84 million.

For earnings history and earnings-related data on G1 Therapeutics, Inc. (GTHX) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Investing.com’s stocks of the week
• AiRWA receives Nasdaq deficiency notice over late 10-K filing